Bosulif 400 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FYRUS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,631
Award facts
- Contract value 100% obligated
- $23,631.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $23,631.26 to AmerisourceBergen Drug Corp for the supply of Bosulif 400 mg tablets (30-count) on September 24, 2025, with an ultimate completion date of October 16, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the vendor's facility in Conshohocken, Pennsylvania. The award is a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999.00 comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical supply requirements through open competition, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The DLA Troop Support Medical contract reflects the company's established role as a primary supplier within the military's medical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DB25FYRUS?
SPE2DB25FYRUS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 24, 2025.
How much is contract SPE2DB25FYRUS worth?
The government has obligated $23,631 on SPE2DB25FYRUS.
Is contract SPE2DB25FYRUS an order under another contract?
Yes. SPE2DB25FYRUS is a delivery order under SPE2DB22D1017, an indefinite delivery contract.
Was contract SPE2DB25FYRUS competed?
The extent of competition for SPE2DB25FYRUS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award